🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cat allergy is an increasingly prevalent condition, affecting 10-15% of pat...
Status
Completed
Location
Alpha Medical Research
Start Date
2009-03
Trial ID
NCT00867906
A study evaluating efficacy and safety of repeated doses of PT027 compared ...
Status
Completed
Location
Research Site
Start Date
2022-09-28
Trial ID
NCT05555290
The purpose of this study is to demonstrate the pharmacodynamic bioequivale...
Status
Completed
Location
Combined Research Orlando
Start Date
2018-10-17
Trial ID
NCT03394989
This study will evaluate the effects of inhaled fluticasone on cell counts ...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00869596
The QUARTZ study is a retrospective observational cohort study using a prev...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-03
Trial ID
NCT07787117
Treatments Being Tested
This study is designed to test the hypothesis that salmeterol use, and not ...
Status
Completed
Location
University of Wisconsin
Start Date
2003-11
Trial ID
NCT00214019
Treatments Being Tested
The purpose of this study is to determine whether the addition of budesonid...
Status
Completed
Location
Children's Hospital of Philadelphia Emergency Department
Start Date
2006-12
Trial ID
NCT00393367
This is a multi-center, randomized, double-blinded, placebo-controlled stud...
Status
Completed
Location
WG Clinical Research
Start Date
2015-04
Trial ID
NCT02397499
The primary objective of this study is to evaluate the dose response, effic...
Status
Completed
Location
Teva Investigational Site 10453
Start Date
2013-01
Trial ID
NCT01772368
Treatments Being Tested
This study evaluates 20% n-acetylcysteine (NAC) in the treatment of moderat...
Status
Terminated
Location
UCSF Airway Clinical Research Center
Start Date
2019-02-20
Trial ID
NCT03822637
Treatments Being Tested